Siemens Healthineers has signed a partnership with the African Medical Centre of Excellence in Nigeria to widen access to advanced diagnostics and cancer care, BusinessDay reported on 18 March. The deal is aimed at slowing the outbound medical travel that has long sent Nigerian patients abroad, the paper said. It is meant to build the treatment capacity to keep them at home. The deal covers medical imaging, precision diagnostics and integrated cancer care. It also adds training, so that the centre’s own clinicians can run the equipment rather than depend on visiting engineers.
A hospital that is already running
The centre is a $300 million multi-specialty hospital backed by Afreximbank and its partners, BusinessDay reported. It began operations in 2025, and it has already carried out open-heart surgeries and advanced cancer treatments, the paper said. That sets it apart from the many hospital projects that are announced across the continent and then quietly shelved. A signed diagnostics deal is a plan until the scanners run; a hospital that has performed open-heart surgery is capacity that already exists. That distinction matters for how the deal should be read. The new imaging and cardiovascular systems fold into a building that is treating patients, not one still on paper.
The centre offers care across oncology, cardiovascular medicine, haematology, radiology and surgery, and the deal adds tools meant to speed early diagnosis. Brian Deaver, chief executive of the centre, said the aim was to “build a centre that delivers internationally benchmarked care” while training clinicians on the continent. Vivek Kanade, managing director for Siemens Healthineers in the Middle East and Africa, described the work as “empowering clinicians” and “strengthening health systems.” He named Tanit Medical Engineering as the firm handling the project. That pairing of equipment and training is the part that decides whether the money holds, because scanners without trained operators produce a showcase, not a service.
The drain the deal is meant to reverse
Nigeria loses both patients and money to treatment abroad, and the deal is one of several moves aimed at keeping the two at home. It reflects a wider push against non-communicable diseases, which account for about 30 per cent of deaths in Nigeria, the paper said. Cardiovascular disease is responsible for roughly 10 per cent. Those numbers are the reason a diagnostics upgrade matters, because cancer and heart care are the conditions that most often send Nigerian patients abroad. They are the conditions the centre is equipping itself to treat closer to home. India dominates Nigeria’s outbound flow for exactly this kind of complex care. Nigerian institutions have spent the past year trying to reverse it, most recently through a military healthcare upgrade built around the same centre.
BusinessDay reported that the deal is part of a broader shift in how African health systems are built. Analysts told the paper that such deals could mark a turning point, away from a reliance on foreign treatment and toward centres able to handle complex care closer to home. That shift is slower than the announcements around it, because a scanner can be installed in weeks while the radiologists to read its images are trained over years. The scanners are the easy half. Training is what turns a diagnostics deal into a working cancer and heart care programme, and it cannot be rushed.
What operators should watch
The test is the same as for any capacity announcement. It is whether the equipment is installed and used, not whether the deal was signed. The figures to watch are the ones the centre can report itself. They are the number of cancer and heart care cases it treats. They are the share of Nigerian patients who once travelled abroad for that care. They are the outbound referrals that should fall as the caseload at home climbs. If the scanners arrive and the caseload does not, the drain will continue whatever the deal promised.
